Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919)

Author： Appel-Dingemanse S. Hirschberg Y. Osborne S. Pommier F. McLeod J.

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.56, Iss.12, 2001-03, pp. : 889-891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multiple-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist

By Dutta S.

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 129-136

Adis International

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection

By Cahn Pedro

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects

By Nunes Teresa

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics and Safety of Bevirimat, a Novel Inhibitor of HIV Maturation, in Healthy Volunteers

By Martin David E.

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 589-598

Adis International

Access to resources Recommend Favorite

Single- and Multiple-Dose Pharmacokinetic and Dose-Proportionality Study of Oxymorphone Immediate-Release Tablets

By Adams Michael P.

Drugs in R&D, Vol. 6, Iss. 2, 2005-01 ,pp. : 91-99

Adis International

Access to resources Recommend Favorite